Pharmanutra S.p.A.

Milan Stock Exchange:PHN.MI

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🏬 Consumer Packaged Goods

💊 Drugstores & Retail Pharmacies

🛍 Retail & Wholesale

🛍 Specialty Retail

Location

Italy

Market Cap

USD 513.19 M

Share Price

USD 53.05

Avg Daily Volume

9,931

Change (1 day)

-1.37%

Change (1 year)

4.48%

Change (YTD)

-6.28%

Pharmanutra S.p.A. Enterprise Value to EBITDA (EV/EBITDA) on June 20, 2025: 15.33

Pharmanutra S.p.A. Enterprise Value to EBITDA (EV/EBITDA) is 15.33 on June 20, 2025, a -9.12% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.

Pharmanutra S.p.A. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 22.11 on June 20, 2025, which is 44.22% above the current Enterprise Value to EBITDA (EV/EBITDA).
Pharmanutra S.p.A. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 14.72 on June 20, 2025, which is -3.99% below the current Enterprise Value to EBITDA (EV/EBITDA).
Pharmanutra S.p.A. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 18.21.

Daily

From:

To:

Zoom:

Key data

Date	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield	Dividend Yield	Market Capitalization

Milan Stock Exchange: PHN.MI

Pharmanutra S.p.A.

CEO	Mr. Andrea Lacorte
IPO Date	July 18, 2017
Location	Italy
Headquarters	Via delle Lenze 216/B
Employees	118
Sector	🏥 Health Care
Industries Pharmaceuticals 🏬 Consumer Packaged Goods 💊 Drugstores & Retail Pharmacies 🛍 Retail & Wholesale 🛍 Specialty Retail

Description

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.